Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Screening and monitoring of TB infection in rheumatological patients on biologics therapy Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
Pneumococcal vaccination in interstitial lung disease patients receiving systemic immunosuppressive treatment Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002
Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Efficiency of treatment regimens for chronic tuberculosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 519s Year: 2003
Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan Source: International Congress 2017 – Migrants and screening Year: 2017
Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence Source: International Congress 2015 – Screening strategies in TB Year: 2015
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Severe pulmonary infections due to biological therapy of rheumatic diseases Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
Relapse and failure pulmonary tuberculosis patients have the chance of cure with major antituberculosis drugs Source: Eur Respir J 2007; 30: Suppl. 51, 657s Year: 2007
Intrabronchial lymphotropic immune and antibiotic therapy in complex treatment of the chronic obstructive disease of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 524s Year: 2004
Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens Source: Annual Congress 2011 - Tuberculosis in special populations Year: 2011
Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021 Year: 2022